Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : Emilie Rossignol

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1

Atherosclerosis knowledge - diagnosis and management in primary care

Marie Charasson , Guillaume Mahé , Charles Le Brun , Vincent Jaquinandi , Emilie Rossignol et al.
VASA, 2018, 47 (6), pp.465-470. ⟨10.1024/0301-1526/a000727⟩
Journal articles hal-01862278v1

Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort

Mylene Sebagh , Claire Fougerou-Leurent , Georges-Philippe Pageaux , Vincent Leroy , Jerome Dumortier et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles hal-01769633v1

Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort

Mylene Sebagh , Claire Fougerou-Leurent , Georges-Philippe Pageaux , Vincent Leroy , Jerome Dumortier et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles hal-01684629v1

Discordant knowledge about atherosclerosis disease among French general practitioners and residents

Marie Charasson , Charles Le Brun , Loukman Omarjee , Emilie Rossignol , Damien Lanéelle et al.
Journal of Vascular Surgery, 2019, 70 (3), pp.1013. ⟨10.1016/j.jvs.2019.04.441⟩
Journal articles hal-02280496v1
Image document

HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation

Audrey Coilly , Mylene Sebagh , C. Fougerou-Leurent , Georges-Philippe Pageaux , Vincent Leroy et al.
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (9), pp.102024. ⟨10.1016/j.clinre.2022.102024⟩
Journal articles hal-03799246v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1